Pharming Group N.V. (AMS:PHARM) Held Back By Insufficient Growth Even After Shares Climb 26%
Dec 21
Have your own idea? Try our Stock Screener
Dutch (AEX) Biotech Industry Analysis
UpdatedJan 03, 2025
DataAggregated Company Financials
Companies3
- 7D6.4%
- 3M10.8%
- 1Y-27.0%
- YTD0%
All of the companies in the Biotech industry have been up over the last week, with the industry up 3.9%. In the past year, the industry is down 28%. In the next few years earnings are forecast to be pretty stable.
Industry Valuation and Performance
Has the Dutch Biotech Industry valuation changed over the past few years?
| Date | Market Cap | Revenue | Earnings | PE | Absolute PE | PS |
|---|---|---|---|---|---|---|
| Fri, 03 Jan 2025 | €2.5b | €538.7m | -€77,988,425.00 | n/a | -31.6x | 4.6x |
| Sun, 01 Dec 2024 | €2.2b | €530.1m | -€77,453,735.00 | n/a | -28.7x | 4.2x |
| Tue, 29 Oct 2024 | €2.3b | €525.6m | €15.0m | 55.8x | 152.2x | 4.3x |
| Thu, 26 Sep 2024 | €2.2b | €510.8m | €19.5m | 53.8x | 110.8x | 4.2x |
| Sat, 24 Aug 2024 | €2.0b | €509.4m | €19.6m | 48.8x | 103.7x | 4x |
| Mon, 22 Jul 2024 | €2.1b | €481.1m | €20.8m | 51.4x | 100.9x | 4.4x |
| Wed, 19 Jun 2024 | €2.1b | €484.2m | €20.7m | 51.5x | 101.4x | 4.3x |
| Fri, 17 May 2024 | €2.4b | €481.3m | €20.8m | 58.8x | 114.7x | 5x |
| Sun, 14 Apr 2024 | €2.6b | €470.3m | -€40,191,065.20 | n/a | -64x | 5.5x |
| Tue, 12 Mar 2024 | €2.8b | €439.9m | -€50,466,147.00 | n/a | -56.3x | 6.5x |
| Thu, 08 Feb 2024 | €3.3b | €747.0m | -€199,831,656.50 | n/a | -16.6x | 4.4x |
| Sat, 06 Jan 2024 | €3.4b | €743.5m | -€199,478,777.00 | n/a | -17.1x | 4.6x |
| Mon, 04 Dec 2023 | €3.2b | €745.1m | -€199,637,573.00 | n/a | -16x | 4.3x |
| Wed, 01 Nov 2023 | €3.0b | €766.8m | -€204,473,770.00 | n/a | -14.7x | 3.9x |
| Fri, 29 Sep 2023 | €3.2b | €755.2m | -€199,155,577.00 | n/a | -16.1x | 4.2x |
| Sun, 27 Aug 2023 | €3.4b | €751.1m | -€200,699,143.00 | n/a | -16.8x | 4.5x |
| Tue, 25 Jul 2023 | €3.6b | €729.7m | -€211,430,488.00 | n/a | -16.9x | 4.9x |
| Thu, 22 Jun 2023 | €3.4b | €732.4m | -€211,457,221.00 | n/a | -16.3x | 4.7x |
| Sat, 20 May 2023 | €3.8b | €737.9m | -€196,988,387.00 | 59.3x | -19.1x | 5.1x |
| Mon, 17 Apr 2023 | €3.3b | €703.0m | -€219,125,599.00 | 53.7x | -15.1x | 4.7x |
| Wed, 15 Mar 2023 | €3.4b | €705.8m | -€203,280,250.00 | 25.1x | -16.9x | 4.9x |
| Fri, 10 Feb 2023 | €3.6b | €777.7m | €20.3m | 234.4x | 178.1x | 4.6x |
| Sun, 08 Jan 2023 | €3.8b | €779.4m | €20.5m | 259.3x | 182.9x | 4.8x |
| Tue, 06 Dec 2022 | €3.5b | €781.8m | €20.9m | 235.9x | 168.6x | 4.5x |
| Thu, 03 Nov 2022 | €4.0b | €722.5m | -€63,381,935.00 | 23.5x | -62.6x | 5.5x |
| Sat, 01 Oct 2022 | €3.8b | €722.3m | -€72,908,229.00 | 32.8x | -52x | 5.3x |
| Mon, 29 Aug 2022 | €4.2b | €718.4m | -€72,398,576.00 | 35.4x | -58.6x | 5.9x |
| Wed, 27 Jul 2022 | €4.0b | €717.5m | -€127,759,675.00 | 47.1x | -31.3x | 5.6x |
| Fri, 24 Jun 2022 | €4.0b | €710.1m | -€128,158,766.00 | 45.3x | -31.5x | 5.7x |
| Sun, 22 May 2022 | €4.2b | €709.5m | -€128,192,661.00 | 48.4x | -32.6x | 5.9x |
| Tue, 19 Apr 2022 | €4.8b | €679.9m | -€122,160,308.00 | 38.1x | -39x | 7x |
| Thu, 17 Mar 2022 | €4.4b | €668.5m | -€117,921,000.00 | 27x | -37.6x | 6.6x |
| Sat, 12 Feb 2022 | €4.7b | €709.9m | -€193,509,000.00 | 29.7x | -24.1x | 6.6x |
| Mon, 10 Jan 2022 | €3.9b | €709.9m | -€193,509,000.00 | 27.1x | -20.2x | 5.5x |
Price to Earnings Ratio
-20.2x
Current Industry PE
- There are only 3 companies in the Dutch Biotechs industry, so there is insufficient data to make an industry-wide assessment of both the PE and PS ratio.
Past Earnings Growth
- The earnings for companies in the Biotechs industry have improved over the last three years.
- Meanwhile revenues for these companies have declined 9.0% per year.
- This means that less sales are being generated overall, but since the cost of doing business is lower, losses have been shrinking.
Industry Trends
Which industries have driven the changes within the Dutch Healthcare industry?
| NL Market | 0.61% | |
| Healthcare | 0.59% | |
| Biotech | 6.36% | |
| Biotech | 6.36% | |
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.
Top Stock Gainers and Losers
Which companies have driven the market over the last 7 days?
| Company | Last Price | 7D | 1Y | Valuation | |
|---|---|---|---|---|---|
| GLPG Galapagos | €27.46 | 5.9% +€101.5m | -27.6% | PS7x | |
| PHARM Pharming Group | €0.96 | 7.5% +€45.4m | -11.4% | PS2.3x | |
| VVY Vivoryon Therapeutics | €2.10 | 6.6% +€3.4m | -73.9% | PB3.9x |